Eurofarma Files for Brazilian Approval of Bavarian Nordic’s Chikungunya Vaccine

Bavarian Nordic A/S (announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory Agency...

July 15, 2026 | Wednesday | News
BioLineRx and Hemispherian Report Promising Preclinical Data for GLIX1-Olaparib Combination in Ovarian Cancer

Synergy was demonstrated in a combination arm of GLIX1 and the PARP inhibitor olaparib at low doses, with substantially better efficacy compared t...

July 10, 2026 | Friday | News
Evogene and Tel Aviv University Launch AI-Driven Small Molecule Drug Discovery Initiative

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the generative design of small molecules for the pharmaceuti...

July 10, 2026 | Friday | News
Abu Dhabi and Biocom California Establish Strategic Gateway Linking Two Leading Life Sciences Ecosystems

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest ...

June 25, 2026 | Thursday | News
Teva Submits NDA for Ecopipam as Potential First-in-Class Treatment for Pediatric Tourette Syndrome

NDA submission supported by positive Phase 3 data recently published in JAMA Neurology. Ecopipam is a first-in-class selective dopamine D1 receptor an...

June 22, 2026 | Monday | News
Innovaccer, Infinia Forge Alliance to Accelerate UAE’s Digital Health Transformation

Innovaccer Inc., a leading healthcare AI company, and Infinia Technologies, a next-generation digital transformation company and a subsidiary of Sirius I...

April 10, 2026 | Friday | News
Humacyte Secures $1.475M Symvess Commitment to Advance Clinical Evaluation in Saudi Arabia

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at comme...

March 20, 2026 | Friday | News
Polyrizon Advances Clinical Pathway With CRO Agreement For Biocompatibility Studies

Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal ad...

March 18, 2026 | Wednesday | News
GenSight Biologics Advances Early Access Programs for LUMEVOQ Gene Therapy in Rare Vision Disorder

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene...

March 10, 2026 | Tuesday | News
ImmunityBio Expands Global Footprint with ANKTIVA Commercialization Partnership in Middle East

Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA) ImmunityBio establi...

February 24, 2026 | Tuesday | News
Bio Usawa and Nanoly Bioscience Partner to Revolutionize Biologic and Vaccine Distribution with DynaShield™

Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical stabilization,  announced a defin...

February 19, 2026 | Thursday | News
Sheba Medical Center First in Israel to Adopt NGD’s Real-Time Transmission Detection System

NGD Infection Prevention, a global provider of real-time genomic transmission detection for hospitals, has deployed an integrated transmission detec...

January 02, 2026 | Friday | News
SciSparc-Backed NeuroThera Secures Israeli Patent for Opioid–N-Acylethanolamine Combination Therapy

SciSparc Ltd.  announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel ...

January 01, 2026 | Thursday | News
Zydus Lifesciences Partners With Formycon to Commercialize Keytruda Biosimilar FYB206 in North America

Zydus Lifesciences Limited (including its subsidiaries and affiliates), an innovation-led life-sciences company, with an international presence...

December 10, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close